Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 14,388 shares at $6.23 ($88K) on 2024-09-18, disclosed to the SEC on 2024-09-20.
Open-market purchase of $88k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.23 | 2,709 | $17K | 19.1% |
| 2 | $6.11 | 11,679 | $71K | 80.9% |
| Total | $6.13 avg | 14,388 | $88K | 100% |
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-08-22 | $15K | — | Filing → |